SciELO - Scientific Electronic Library Online

vol.50 número1Sigmoid volvulus: Long-term clinical outcome and review of the literatureGuideline summary: Appropriate use of tigecycline índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados



Links relacionados

  • En proceso de indezaciónCitado por Google
  • En proceso de indezaciónSimilares en Google


South African Journal of Surgery

versión On-line ISSN 2078-5151
versión impresa ISSN 0038-2361

S. Afr. j. surg. vol.50 no.1 Cape Town feb. 2012




Fournier's gangrene - analysis of management and outcome in south-eastern Nigeria



F. O. UgwumbaI; I. I. NnabugwuII; O. F. N. OzoemenaIII

IM.B. B.S., F.W.A.C.S., F.I.C.S.; Urology Unit, Department of Surgery, University of Nigeria Teaching Hospital, Enugu, Enugu State, Nigeria
IIB. B.S., F.W.A.C.S.; Urology Unit, Federal Medical Centre, Asaba, Delta State, Nigeria
IIIM.B. B.S., F.W.A.C.S., F.I.C.S.; Urology Unit, Department of Surgery, University of Nigeria Teaching Hospital




BACKGROUND: Fournier's gangrene is a necrotising fasciitis of the genitalia and perineum, with associated polymicrobial infection and risk of organ failure or death. The purpose of this study was to determine the presentation, systemic and local predisposing factors, management challenges and outcome in south-eastern Nigeria.
PATIENTS AND METHODS: We studied 28 out of 34 consecutive male patients with complete case notes seen in two centres (the University of Nigeria Teaching Hospital and St Mary's Hospital) between January 1995 and December 2008. Operating theatre registers and urology ward admission registers were used to identify patients.
RESULTS:. The mean patient age was 48.3 years (range 28 - 66 years), with a peak age incidence of 50 - 59 years. The majority of patients were farmers, manual labourers and artisans. The site of gangrene was scrotal in 22 patients (78.6%), penoscrotal in 3 (10.7%), abdominoscrotal in 2 (7.1%) and scroto-perianal in 1 (3.6%). The mean interval between onset of symptoms and presentation was 7.2 days (range 3 - 14 days). Systemic predisposing factors identified were diabetes mellitus in 6 patients (21.4%), filariasis in 2 (7.2%), congestive cardiac failure in 1 (3.6%) and HIV infection in 1 (3.6%). In 18 patients (64.3%) no systemic factor was identified. Local predisposing factors identified were chronic scrotal skin itching in 16 patients (57.1%), scrotal thorn injury in 2 (7.1%) and urethral catheterisation in 2 (7.1%). Scrotal carbuncle and scrotal surgery each accounted for 2 patients (7.1%), and zipper injury and ischiorectal abscess occurred in 1 patient each (3.6%). No local predisposing factor was identified in 1 patient (3.6%). The common clinical features were fever, scrotal swelling/pain, and later a malodorous painless wound. Treatment involved fluid administration, correction of electrolyte imbalance, antibiotics, debridement and daily wound inspection/ dressing with hydrogen peroxide soaks and sodium hypochlorite. The mean duration of hospital stay was 37.1.days (range 21 - 84 days). One patient died (3.6%).
CONCLUSION: Fournier's gangrene is a challenging surgical problem, with significant morbidity. Diabetes mellitus is a significant systemic risk factor. In the majority of our cases, no systemic predisposing factor was identified. Local risk factors, especially chronic scrotal itching, were contributory. With proper management, mortality is low.


“Full text available only in PDF format”



1. Ong HS, Ho YH. Genitoperineal gangrene: experience in Singapore. Aust N Z J Surg 1996;66:291-293.         [ Links ]

2. Stephens BJ, Lathrop JC, Rice WT, Gruenberg JC. Fournier's gangrene: historic (1764-1978) versus contemporary (1979-1988) differences in etiology and clinical importance. Am Surg 1993;59:149-154.         [ Links ]

3. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier's gangrene. J Urol 1995;154:89-92.         [ Links ]

4. Nathan B. Fournier's gangrene: a historical vignette. Can J Surg 1998;41:72.         [ Links ]

5. Beniziri E, Fabiani P, Migliori G, et al. Gangrene of the perineum. Urology 1996;47:935-939.         [ Links ]

6. Eke N. Fournier's gangrene: a review of 1726 cases. Br J Surg 2000;87:718-728.         [ Links ]

7. Elliot DC, Kufera JA, Myers RAM. Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg 1996;224:672-683.         [ Links ]

8. Hejase MJ, Simonin JE, Birhle R, Coogam CL. Genital fournier's gangrene: Experience in 38 patients. Urology 1996;47:734-739.         [ Links ]

9. Efem SE. Recent advances in the management of Fournier's gangrene. Preliminary observations. Surgery 1993;113:200-204.         [ Links ]

10. Eke N. Fournier's gangrene: the Nigerian experience. Nig Postgrad Med J 1999;6:99-102.         [ Links ]

11. Salvino C, Harford FJ, Dobrin PB. Necrotizing infections of the perineum. South Med J 1993;86:908-911.         [ Links ]

12. Fialkov JM, Watkins K, Fallon B, Kealy GP. Fournier's gangrene with an unusual urologic aetiology. Urology 1998;52:324-327.         [ Links ]

13. Hollabaugh RS Jr, Dmochowski RR, Hickerson WL, Cox CE. Fournier's gangrene: therapeutic impact of hyperbaric oxygen. Plast Reconstr Surg 1998;101:94-100.         [ Links ]

14. Smith GL, Bunker CB, Dinneen MD. Fournier's gangrene. Br J Urol 1998;81:532-533.         [ Links ]

15. Ayan F, Sunamak O, Paksoy SM, et al. Fournier's gangrene: A retrospective clinical study on forty one patients. Aust N Z J Surg 2005;75:1055-1058.         [ Links ]

16. United Nations Development Programme. International Human Development Indicators: Nigeria. (accessed 6 January 2010).         [ Links ]

17. Safioleas M, Stamatakos G, Mouzopoulos A, et al. Fournier's gangrene: Exists and it is still lethal. Int Urol Nephrol 2006;38:653-657.         [ Links ]

18. Nisbet AA, Thompson IM. Impact of diabetes mellitus on the presentation and outcomes of Fournier's gangrene. Urology 2002;60:775-779.         [ Links ]

19. Dahm P, Roland FH, Steven NV, et al. Outcome analysis in patients with primary necrotizing fasciitis of the male genitalia. Urology 2000;56:31-35.         [ Links ]

20. Ullah S, Khan M, Asad Uilah Jan M. Fournier's gangrene: a dreadful disease. Surgeon 2009;3:138-142.         [ Links ]

21. Akunyili D. Battling against counterfeit drugs. Interview by Marilynn Larkin. Lancet Infect Dis 2006;6(9):554-555.         [ Links ]

22. Villanueva-Saenz E, Martinez-Hernandez-Magro P, Valdez-Ovalle M, Montez-Vega J, Alvarez-Tostado JFF. Experience in management of Fournier's gangrene. Tech Coloproct 2002;6:5-13.         [ Links ]

23. Rajbhandari SM, Wilson RM. Unusual infections in diabetes. Diabetes Res Clin Pract 1998;39:123-128.         [ Links ]

24. Shupak A, Shosani O, Goldenberg I, Barzilai A, Moskuna R, Bursztein S. Necrotizing fasciitis: an indication for hyperbaric oxygen therapy? Surgery 1995;118:873-878.         [ Links ]

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons